Cytovance Biologics logo

Cytovance Biologics

We are Cytovance Biologics, your responsive, reliable, and resourceful CDMO Partner.

206 employees · est. 2003 · Oklahoma City, United States

VS
神州细胞工程有限公司 logo

神州细胞工程有限公司

Pioneering accessible and affordable biological medicines through advanced protein and antibody technologies.

91 employees · est. 2007

Cytovance Biologics is the older company (2003 vs 2007); Cytovance Biologics is the larger of the two.

Side-by-Side Comparison

Cytovance Biologics 神州细胞工程有限公司
Founded
2003 older 2007
Headquarters
Oklahoma City, United States Not tracked yet
Employees
206 larger 91
Industry
Biotechnology, Manufacturing Biotechnology, Health Care, Manufacturing
Funding Stage
Debt Financing Series A
Total Funding
$42.50M $200.00M
Funding Rounds
2 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
CDMO Partner, Biologics Manufacturing, Therapeutic Proteins, Antibody Production, Cell Line Development, Process Development, Purification Development, CGMP Manufacturing, Analytical Development Support, Regulatory Support, Microbial Fermentation, Mammalian Cell Culture, R&D Services, Tech Transfer Biotech, Recombinant Proteins, Monoclonal Antibodies, Vaccines, Protein Expression, Cell Line Development, Serum-free Medium, Fed-batch Cell Culture, Process Scale-up, Protein Purification, Biological Medicines, Affordable Healthcare, Technology, Innovation, Cost Reduction
Website
cytovance.com sinocelltech.com
Cytovance Biologics logo

About Cytovance Biologics

Cytovance Biologics is a leading player in the biotechnology and manufacturing industries. Established in 2003, the company prides itself on being a responsive, reliable, and resourceful partner in the contract development and manufacturing (CDMO) landscape. With a strong emphasis on advancing the c...

神州细胞工程有限公司 logo

About 神州细胞工程有限公司

神州细胞工程有限公司 (Sinocelltech) is a biotech firm founded in 2007 with the slogan "Pioneering accessible and affordable biological medicines through advanced protein and antibody technologies." The company is focused on the development and production of recombinant proteins, monoclonal antibodie...

We will tell you when either one moves

BounceWatch watches Cytovance Biologics and 神州细胞工程有限公司 for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cytovance Biologics and 神州细胞工程有限公司 — by email.

Frequently Asked Questions

Cytovance Biologics — We are Cytovance Biologics, your responsive, reliable, and resourceful CDMO Partner.. 神州细胞工程有限公司 — Pioneering accessible and affordable biological medicines through advanced protein and antibody technologies.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cytovance Biologics has raised $42.50M while 神州细胞工程有限公司 has raised $200.00M.
Cytovance Biologics and 神州细胞工程有限公司 operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cytovance Biologics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cytovance Biologics on 6 Dec 2024, and 神州细胞工程有限公司 on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy